Laura Kopplin is an Ophthalmology physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 82 publications with 1,782 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 Highland Ave
Madison, WI 53792
Telephone
608-263-6070Provider last certified this registry record 15 Jan 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Apellis Pharmaceuticals, Inc.Program year20241 payment
- Bausch & Lomb Americas Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
56.6%Corticosteroid17.7%Prednisolone Acetate95%Fluorometholone6%Part D<11 patientsProstaglandin Analog14.2%Latanoprost100%Part D≥41 patients+ 4 more classes in this area
Cancer & immunology
17.8%Folate Analog Metabolic Inhibitor7.9%Methotrexate100%Part D≥20 patientsCalcineurin inhibitor4.1%Restasis75%Cequa26%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
6.7%Corticosteroid5.4%Prednisone100%Part D≥20 patientsAntidiarrheal microorganisms1.3%Folic Acid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Barriers to Adherence with Clinic Visits in Patients with Uveitis
Ocular Immunology and Inflammation
2025 - Barriers to Adherence with Immunosuppressive Therapy in Patients with Uveitis
Ocular Immunology and Inflammation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Albertini, MD
University of Wisconsin–Madison
Bryn Webb, MD
University of Wisconsin–Madison
Jeannina Smith, MD
University of Wisconsin–Madison
Carolina Pusec, PhD, MD
University of Wisconsin–Madison
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”